Stay updated on Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-10-10T08:18:57.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-10-03T04:47:45.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in displaying study record information.
    Difference
    2%
    Check dated 2024-09-25T22:19:23.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    ClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.
    Difference
    1%
    Check dated 2024-09-18T16:30:05.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-09-11T07:17:57.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.8%
    Check dated 2024-09-04T04:20:19.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.